Log In
BCIQ
Print this Print this
 

API-001

  Manage Alerts
Collapse Summary General Information
Company Shanghai Ambrosia Pharmaceuticals Co. Ltd.
DescriptionInhibitor of TNFa /NF-kB signaling
Molecular Target Tumor necrosis factor (TNF) alpha ; Nuclear factor of kappa light polypeptide gene enhancer in B cells 1 (NF-kB) (NFKB1) (p105) (p50)
Mechanism of ActionTumor necrosis factor (TNF) alpha convertase inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentDiscovery
Standard Indication Inflammation (unspecified)
Indication DetailsTreat inflammation
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today